PLoS ONE (Jan 2012)

LMNA knock-down affects differentiation and progression of human neuroblastoma cells.

  • Giovanna Maresca,
  • Manuela Natoli,
  • Marta Nardella,
  • Ivan Arisi,
  • Daniela Trisciuoglio,
  • Marianna Desideri,
  • Rossella Brandi,
  • Simona D'Aguanno,
  • Maria Rita Nicotra,
  • Mara D'Onofrio,
  • Andrea Urbani,
  • Pier Giorgio Natali,
  • Donatella Del Bufalo,
  • Armando Felsani,
  • Igea D'Agnano

DOI
https://doi.org/10.1371/journal.pone.0045513
Journal volume & issue
Vol. 7, no. 9
p. e45513

Abstract

Read online

BackgroundNeuroblastoma (NB) is one of the most aggressive tumors that occur in childhood. Although genes, such as MYCN, have been shown to be involved in the aggressiveness of the disease, the identification of new biological markers is still desirable. The induction of differentiation is one of the strategies used in the treatment of neuroblastoma. A-type lamins are components of the nuclear lamina and are involved in differentiation. We studied the role of Lamin A/C in the differentiation and progression of neuroblastoma.Methodology/principal findingsKnock-down of Lamin A/C (LMNA-KD) in neuroblastoma cells blocked retinoic acid-induced differentiation, preventing neurites outgrowth and the expression of neural markers. The genome-wide gene-expression profile and the proteomic analysis of LMNA-KD cells confirmed the inhibition of differentiation and demonstrated an increase of aggressiveness-related genes and molecules resulting in augmented migration/invasion, and increasing the drug resistance of the cells. The more aggressive phenotype acquired by LMNA-KD cells was also maintained in vivo after injection into nude mice. A preliminary immunohistochemistry analysis of Lamin A/C expression in nine primary stages human NB indicated that this protein is poorly expressed in most of these cases.Conclusions/significanceWe demonstrated for the first time in neuroblastoma cells that Lamin A/C plays a central role in the differentiation, and that the loss of this protein gave rise to a more aggressive tumor phenotype.